Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.94
+0.45 (1.58%)
At close: Feb 27, 2026, 4:00 PM EST
29.00
+0.06 (0.21%)
After-hours: Feb 27, 2026, 7:42 PM EST
Roivant Sciences Employees
Roivant Sciences had 750 employees as of March 31, 2025. The number of employees decreased by 158 or -17.40% compared to the previous year.
Employees
750
Change (1Y)
-158
Growth (1Y)
-17.40%
Revenue / Employee
$17,747
Profits / Employee
-$1,078,987
Market Cap
20.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 750 | -158 | -17.40% |
| Mar 31, 2024 | 908 | 4 | 0.44% |
| Mar 31, 2023 | 904 | 41 | 4.75% |
| Mar 31, 2022 | 863 | 198 | 29.77% |
| Jun 30, 2021 | 665 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 6,772 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Ionis Pharmaceuticals | 1,069 |
| BridgeBio Pharma | 839 |
ROIV News
- 22 days ago - Roivant: The Next Telavant Has Arrived With Brepocitinib's Blockbuster Data (Rating Upgrade) - Seeking Alpha
- 22 days ago - Roivant Sciences Ltd. (ROIV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - GlobeNewsWire
- 22 days ago - Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) - GlobeNewsWire
- 22 days ago - Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025 - GlobeNewsWire
- 5 weeks ago - Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 - GlobeNewsWire
- 6 weeks ago - Roivant Sciences Ltd. (ROIV) Presents at 44th Annual J.P. - Seeking Alpha
- 7 weeks ago - Roivant Sciences Ltd. (ROIV) Q2 2025 Earnings Call Transcript - Seeking Alpha